Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 318 for “"Anti-HIV"”.
-
Synthetic and structural studies on anti-HIV agents
… on synthesis and biological evaluation of anti-HIV agents. The leads for the three projects discussed were obtained from the National Cancer Institute’s developmental therapeutics program.</p> <p>Recently, there has been a lot of interest in compounds that target the highly conserved …
-
Development of a Modular Anti-HIV Transducer Protein
The combination antiretroviral therapy (cART) suppresses Human Immunodeficiency Virus (HIV) infection and allows restored long-term health in people living with the HIV. Current treatment provided infection management but not a complete cure. In the absence of treatment, virus level rebound due to …
-
Transport Phenomena in Anti-HIV Microbicide Delivery Vehicles
… were 2.5 million people newly infected with HIV in 2007, clearly motivating the need for additional novel prevention methods. In response, topical vaginal antimicrobials, or microbicides, are being developed. These products aim to stop HIV transmission through local, vaginal delivery of …
-
Mechanistic Models of Anti-HIV Microbicide Drug Delivery
<p>A new modality for preventing HIV transmission is emerging in the form of topical microbicides. Some clinical trials have shown some promising results of these methods of protection while other trials have failed to show efficacy. Due to the relatively novel nature of microbicide drug transport, …
-
Synthetic studies on anti-cancer and anti-HIV compounds
… inhibitor. This compound (NSC-108406) was substantially more potent than the other inhibitors identified during their screening with an IC50 of 0.5 ± 0.3 μM. During a cell-based antiviral screen, it was found to provide an EC50 of 1.5 ± 1.0 μM. In an effort to increase the potency of the lead, a …
-
Design and Construction of an Anti-HIV Protease Transducer
Current therapies against HIV, mainly the highly active anti-retroviral therapy (HAART), concentrate on reducing the viral load and recovering CD4 levels, however they are faced with a rebound of HIV levels on cessation of therapy. Also of concern is the number of reports on resistance to such …
-
The Innate Anti-HIV-1 Activity of Human Seminal Plasma
Human immunodeficiency virus (HIV) has become a global pandemic over the past few decades, with new infections and related deaths in the millions each year. There is no cure in sight for HIV-1 infection, and there has been little progress in developing an efficacious vaccine. Heterosexual …
-
Development of Catalytic RNAs as Potential Anti-HIV-1 Agents
… activity (ribozymes) targeted to the genome of HIV-1 were developed and demonstrated to mediate site-specific cleavage of the HIV-1 RNA in vitro and to inhibit viral proliferation intracellularly. Two classes of ribozymes that incorporate a "hammerhead" catalytic center were utilized, eotide …
-
Understanding and Manipulating Anti-HIV Antibody Responses via Structural Methods
Anti-HIV antibody responses offer one of very few potential routes towards a protective HIV vaccine; structural biochemistry methods such as crystallography and computational modeling can provide key insights for the design of candidate vaccine components and enhance the evaluation of complex …
-
Studies towards the total synthesis of an anti-HIV natural product
<p>This thesis primarily concerns progress made towards the total synthesis of the natural product unciaphenol. The first half of Chapter 1 serves as an introduction to the target molecule and closely related enediyne natural products. This includes biological activity, proposed biosynthetic …
-
In vitro selection and characterisation of human anti-HIV-1 antibody fragments
Generation of neutralising antibodies with broad specificity would be one of the effective approaches to control HIV-1 spread. It is clear that a method that allows rapid generation of neutralising antibodies is needed. This project aims at developing a novel approach to rapidly access human …
-
Structural Characterization of the anti-HIV-1 Broadly Neutralizing Monoclonal Antibody 2F5
Human immunodeficiency virus type 1 (HIV-1), the pathogen responsible for the onset of acquired immuno-deficiency syndrome (AIDS) in humans has reached pandemic proportions. To this day, no cure is available for infection with this virus and the only treatment option for this chronic infection is …
-
Therapeutic Uses of Broadly Neutralizing Anti-HIV-1 Antibodies in Humanized Mice
Combination anti-retroviral drug therapy (ART) significantly suppresses HIV-1 viremia in most infected individuals, but is incapable of curing disease. The major barrier to HIV-1 cure is a population of long-lived cells that harbor replication-competent provirus and are refractory to current …
-
Smart hydrogel for enzyme responsive vaginal delivery of anti-HIV peptide therapeutics
… for advanced formulations for the delivery of anti-retrovirals, a stimuli sensitive hydrogel formulation that intravaginally delivers HIV-1 entry inhibitor upon being exposed to a specific protease was developed. The hydrogel formulation consists of PEG-azide and PEG-DBCO covalently linked to …
-
Enhancement of anti-HIV-1 Ribozyme Activities by Rev Binding and Multimerization
… target. Human immunodeficiency virus type1 (HIV- 1) infectivity is dependent on env gene expression. HIV-1 Rev protein binds to a higher ordered RNA structure within the env transcript termed the Rev Binding Element (RBE). In anti-HIV gene therapy employing ribozymes to increase the …
-
STUDIES ON THE MECHANISMS OF ANTI-HIV-1 FUNCTIONS OF APOBEC3F AND APOBEC3G
… within them. The A3 proteins are potent antiviral restriction factors capable of inhibiting retrotransposons and both exogenous and endogenous retroviruses. The overall goal of my Ph.D. research was to biochemically characterize the A3 enzymes, APOBEC3F (A3F) and APOBEC3G (A3G) and …
-
Viral Diversity by Deep Sequencing: Approaches to Analyzing Effects of Anti-HIV Treatments
HIV is a deadly virus responsible for the AIDS pandemic, which has claimed countless lives since its origins in the early 1980s. A cure for HIV is still elusive - HIV can exist as a diverse and dynamic population that adapts quickly to immune and drug pressures, making elimination of infection …
-
Longitudinal development of broadly neutralising anti-HIV antibodies against the N332 glycan site
Since the isolation of the HIV-1 virus in 1983 our growing knowledge of basic virology has lead to multiple treatment strategies, turning a previously rapid terminal infection into a chronic manageable disease. A protective vaccine is urgently required to stem the rate of new HIV infections …
Page 1 of 16